A.L.L.
Showing 1 - 25 of >10,000
Periodontitis Trial in Alexandria (Subgingival application of L-PRF loaded with metronidazole, Subgingival application of L-PRF)
Completed
- Periodontitis
- Subgingival application of L-PRF loaded with metronidazole
- Subgingival application of L-PRF
-
Alexandria, EgyptFaculty of Dentistry, Alexandria University
Nov 23, 2023
Pregnancy, Malaria, Nutrition Trial (L-citrulline)
Not yet recruiting
- Pregnancy
- +5 more
- L-citrulline
- (no location specified)
Jun 28, 2023
Amyotrophic Lateral Sclerosis Trial (Acetyl-l-carnitine, Placebo)
Not yet recruiting
- Amyotrophic Lateral Sclerosis
- Acetyl-l-carnitine
- Placebo
- (no location specified)
Nov 9, 2023
Stress Trial in London (AlphaWave® L-Theanine, Placebo)
Recruiting
- Stress
- AlphaWave® L-Theanine
- Placebo
-
London, Ontario, CanadaKGK Science Inc.
Mar 30, 2023
Nasolabial Folds Trial (No-Treatment Control, HAC 20L)
Not yet recruiting
- Nasolabial Folds
- No-Treatment Control
- HAC 20L
- (no location specified)
Aug 25, 2023
Osteoarthritis, Knee Trial (L-arginine tablet, Placebo tablet)
Not yet recruiting
- Osteoarthritis, Knee
- L-arginine tablet
- Placebo tablet
- (no location specified)
Sep 19, 2023
Liver Failure, Acute Trial in New Delhi (L-ornithine L-Aspartate, Placebo)
Not yet recruiting
- Liver Failure, Acute
- L-ornithine L-Aspartate
- Placebo
-
New Delhi, IndiaInstitute of Liver and Biliary Sciences
Mar 9, 2023
Visceral Obesity, Non-Alcoholic Fatty Liver Disease Trial in Reus (Multi-ingredient of L-histidine, L-serine, L-carnosine and
Not yet recruiting
- Visceral Obesity
- Non-Alcoholic Fatty Liver Disease
- Multi-ingredient of L-histidine, L-serine, L-carnosine and N-Acetylcysteine
- Placebo
-
Reus, SpainEurecat
Mar 28, 2023
Healthy Trial in Collecchio (Probiotic capsule, Placebo)
Completed
- Healthy
- Probiotic capsule
- Placebo
-
Collecchio, Parma, ItalyCentro Sportivo Parma Football
Oct 16, 2023
Nerve Injury Trial in Hamilton (Temporary Peripheral Nerve Stimulator)
Recruiting
- Nerve Injury
- Temporary Peripheral Nerve Stimulator
-
Hamilton, Ontario, Canada
- +2 more
Feb 1, 2023
Diabetic Peripheral Neuropathic Pain Trial in Luoyang (HSK16149 20mg BID)
Recruiting
- Diabetic Peripheral Neuropathic Pain
- HSK16149 20mg BID
-
Luoyang, Henan, ChinaThe First Affiliated Hospital of Henan University of Science and
Nov 2, 2023
HER-2 Positive Advanced Solid Tumors Trial (D3L-001)
Not yet recruiting
- HER-2 Positive Advanced Solid Tumors
- D3L-001
- (no location specified)
Jul 20, 2023
Osteoporosis Trial in Seoul (PBK_L2201, Placebo)
Not yet recruiting
- Osteoporosis
- PBK_L2201
- Placebo
-
Seoul, Korea, Republic ofThe Catholic University of Korea Yeouido Saint Mary's Hospital
Nov 29, 2023
Gingival Papillary Cratering Trial in Cairo (Hyaluronic acid gel, Multilayer L-PRF membranes)
Completed
- Gingival Papillary Cratering
- Hyaluronic acid gel
- Multilayer L-PRF membranes
-
Cairo, Egyptfaculty of Dentistry. Ain Shams University
Jul 19, 2023
COPD (COPD) Trial in Lund (L-menthol, Placebo)
Not yet recruiting
- Chronic Obstructive Pulmonary Disease (COPD)
- L-menthol
- Placebo
-
Lund, SwedenLund University
May 24, 2023
Epilepsy Trial (Cognitive Intervention)
Not yet recruiting
- Epilepsy
- Cognitive Intervention
- (no location specified)
Jul 12, 2023
Heart Failure Trial in Milan (L-arginine and liposomal vitamin C)
Recruiting
- Heart Failure
- L-arginine and liposomal vitamin C
-
Milan, Lombardia, ItalyFondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Sep 12, 2023
Lung Cancer Trial (Centipeda minima+PD-1/PD-L1 inhibitor, PD-1/PD-L1 inhibitor)
Not yet recruiting
- Lung Cancer
- Centipeda minima+PD-1/PD-L1 inhibitor
- PD-1/PD-L1 inhibitor
- (no location specified)
Feb 17, 2023
Arrhythmia Trial in Oklahoma City (Kardia 12L)
Recruiting
- Arrhythmia
- Kardia 12L
-
Oklahoma City, OklahomaUniversity of Oklahoma Health Sciences Center
Nov 7, 2022
Pulmonary Arterial Hypertension Trial in Adelaide (L608 Inhalation Solution, Placebo solution)
Not yet recruiting
- Pulmonary Arterial Hypertension
- L608 Inhalation Solution
- Placebo solution
-
Adelaide, South Australia, AustraliaCMAX Clinical Research Pty Ltd
Jul 12, 2023
Type 2 Diabetes Trial in Daejeon (CT-L01 12.5/1,000 mg)
Completed
- Healthy
- CT-L01 12.5/1,000 mg
-
Daejeon, Korea, Republic ofChungnam National University Hospital
Jan 10, 2023